Pneumocystis Pneumonia and the Rheumatologist: Which Patients Are At Risk and How Can PCP Be Prevented?
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pneumocystis Pneumonia and the Rheumatologist: Which Patients Are At Risk and How Can PCP Be Prevented?
Authors
Keywords
Pneumocystis pneumonia, Granulomatosis with polyangiitis, Systemic lupus erythematosus, Inflammatory myopathy, Trimethoprim-sulfamethoxazole, Prophylaxis
Journal
Current Rheumatology Reports
Volume 19, Issue 6, Pages -
Publisher
Springer Nature
Online
2017-05-09
DOI
10.1007/s11926-017-0664-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pneumocystis jirovecii pneumonia in systemic autoimmune rheumatic disease: A case–control study
- (2017) Susan Tadros et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Pneumocystis jirovecii Pneumonia in the Non–HIV-Infected Population
- (2016) Laura J. Avino et al. ANNALS OF PHARMACOTHERAPY
- EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
- (2016) M Yates et al. ANNALS OF THE RHEUMATIC DISEASES
- Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis
- (2015) Andreas Kronbichler et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Pneumocystis jirovecii Pneumonia in Patients With Autoimmune Disease on High-Dose Glucocorticoid
- (2015) Li-Ching Chew et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Pneumocystis Pneumonia in Patients with Autoimmune Diseases: A Retrospective Study Focused on Clinical Characteristics and Prognostic Factors Related to Death
- (2015) Minjiang Chen et al. PLoS One
- Pneumocystis jirovecci pneumonia in connective tissue diseases: Comparison with other immunocompromised patients
- (2015) Andrew J. Teichtahl et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Biologic Therapies in Rheumatoid Arthritis and the Risk of Opportunistic Infections: A Meta-analysis
- (2014) Irene S. Kourbeti et al. CLINICAL INFECTIOUS DISEASES
- Positivity for anti-RNP antibody is a risk factor for adverse effects caused by trimethoprim–sulfamethoxazole, a prophylactic agent for P. jiroveci pneumonia, in patients with connective tissue diseases
- (2014) Reika Maezawa et al. Modern Rheumatology
- Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
- (2014) Loïc Guillevin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases
- (2014) Yongfeng Zhang et al. RHEUMATOLOGY INTERNATIONAL
- Pneumocystis jirovecii Pneumonia in Patients Receiving Tumor-Necrosis-Factor-Inhibitor Therapy: Implications for Chemoprophylaxis
- (2014) James A. Grubbs et al. Current Rheumatology Reports
- Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study
- (2013) John W Baddley et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis
- (2013) Ulrich Specks et al. NEW ENGLAND JOURNAL OF MEDICINE
- Colonization by Pneumocystis jirovecii and Its Role in Disease
- (2012) A. Morris et al. CLINICAL MICROBIOLOGY REVIEWS
- Incidence rate and causes of infection in Thai systemic sclerosis patients
- (2012) Chingching Foocharoen et al. International Journal of Rheumatic Diseases
- Outcome of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction in patients without human immunodeficiency virus infection
- (2012) EMILIA HARDAK et al. RESPIROLOGY
- Recent-onset systemic lupus erythematosus complicated by acute respiratory failure
- (2012) M. Kristen Demoruelle et al. ARTHRITIS CARE & RESEARCH
- Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients with Connective Tissue Diseases
- (2011) Passawee Vananuvat et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Pneumocystis jiroveci pneumonia in giant cell arteritis: A case series
- (2011) Tanaz A. Kermani et al. ARTHRITIS CARE & RESEARCH
- Wegener’s granulomatosis: experience from a Brazilian tertiary center
- (2010) Fernando Henrique Carlos de Souza et al. CLINICAL RHEUMATOLOGY
- A Survey of Rheumatologists' Practice for Prescribing Pneumocystis Prophylaxis
- (2010) D. CETTOMAI et al. JOURNAL OF RHEUMATOLOGY
- Methotrexate Drug Interactions in the Treatment of Rheumatoid Arthritis: A Systematic Review
- (2010) J. BOURRE-TESSIER et al. JOURNAL OF RHEUMATOLOGY
- Is There a Role for Consensus Guidelines for P. jiroveci Pneumonia Prophylaxis in Immunosuppressed Patients with Rheumatic Diseases?
- (2010) L. K. STAMP et al. JOURNAL OF RHEUMATOLOGY
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
- (2010) Rachel B. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Infectious Complications in Polymyositis and Dermatomyositis: A Series of 279 Patients
- (2010) Isabelle Marie et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granulomatosis
- (2010) Boris Hugle et al. ARTHRITIS CARE & RESEARCH
- Prophylactic Antibiotic Usage for Pneumocystis jirovecii Pneumonia in Patients With Systemic Lupus Erythematosus on Cyclophosphamide
- (2008) Deepak Gupta et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started